One would almost think he is lobbying for a SRPT position (CEO/Chairman would be nice)
He completely and absolutely discredited himself in his last piece - with comparisons that were definitely very off-base. And just continues with his "slowing down the company in the lead". Which of the two companies has run multiple randomized trials. Which has treated just a few handfuls of patients in unrandomized fashion? Have to wonder if he has some particular interest or has lost his marbles?